eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-ALXO-ALX Oncology Holdings Inc

ALX Oncology Holdings Inc ALXO

‎$‎2.18-0.01(-0.46%)(1D)
• Delayed prices by NASDAQ • in USD
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Price Target
4.33
Based on analysts who covered ALXO
Invest in ALX Oncology Holdings Inc
Today
Create an eToro account to buy ALXO stock on a secure, user-friendly, multi-asset trading platform.
Buy ALX Oncology Holdings Inc
ALX Oncology Holdings Inc ALXO
Buy ALXO

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

ALX Oncology Holdings Inc News

ALXO Stock Price Chart

‎-10.33‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered by
*Past performance is not an indication of future results
Asset stable trend

The ALX Oncology Holdings Inc share price is stable this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The ALX Oncology Holdings Inc share price today is ‎$‎2.18, reflecting a ‎-0.46‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of ALXO is ‎$‎286.91M with an average volume in the last three months of 614057.12. The stock has a P/E ratio of -1.15 and a dividend yield of 0%. With the stock’s beta sitting at 1.45
Why invest in stocks on eToro?
Start with ‎$‎50

Start with ‎$‎50

Low fees

Low fees

users worldwide

users worldwide

Across 70+ countries

Across 70+ countries

BackgroundPhone
Get Started
BackgroundPhone
ALXO Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎286.91M
Day’s Range
i
Shows the high and low prices of the day.
‎$‎2.12 - ‎$‎2.26
52W Range
i
Shows the high and low prices of the last year.
‎$‎0.4047 - ‎$‎2.62
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
614057.12
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-1.15
Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎0
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎2.18
EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎-1.9
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.45

How can I buy ALX Oncology Holdings Inc stocks?

To purchase ALX Oncology Holdings Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the ALX Oncology Holdings Inc (ALXO) page and place an order to buy ALX Oncology Holdings Inc.
Buy ALXO
Looking for more information? Check out our guide on Academy.
What Is ALX Oncology Holdings Inc?
ALX Oncology Holdings Inc is a clinical-stage biopharmaceutical company focused on the development of novel cancer therapies that block the CD47 checkpoint pathway, a process prominent in various forms of cancer. ALX's pipeline includes a range of drug candidates targeting a variety of cancer types, including breast cancer, non-small cell lung cancer and pancreatic cancer.

ALX operates in the biopharmaceutical sector and is committed to developing innovative and effective therapies for cancer patients. The company cultivates its life-saving endeavours across a network of clinical trials and strives to extend survival expectations for patients.

Diversify your virtual portfolio by following ALXO shares on eToro.
CEO
Jason Lettmann, MBA
Employees
43
Founded
2015
HQ
South San Francisco, California, US
Med Tech
NASDAQ
Get Started
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2026
Top Dividend Stocks for 2026
Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.
Read More
AI Stocks Poised for Growth in 2026
AI Stocks Poised for Growth in 2026
Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy ALX Oncology Holdings Inc
Invest in ALX Oncology Holdings Inc
Today
Create an eToro account to buy ALXO stock on a secure, user-friendly, multi-asset trading platform.
Get Started

FAQ

The current price of ALXO is ‎$‎2.18.
The average price target for ALX Oncology Holdings Inc is ‎$‎4.33. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for ALX Oncology Holdings Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of ALX Oncology Holdings Inc is ‎$‎286.91M
Based on 3 analysts offering recommendations for ALXO in the last 3 months, the overall consensus is .
Daily Movers
Explore the biggest stocks movers on the market.
Buy ALXO
English (UK)English (UK)Check icon
DeutschDeutsch
FrançaisFrançais
PolskiPolski
PortuguêsPortuguês
DanskDansk
SuomiSuomi
EspañolEspañol
РусскийРусский
العربيةالعربية
NederlandsNederlands
SvenskaSvenska
RomânăRomână
ItalianoItaliano
中文中文
繁體中文繁體中文
NorskNorsk
ČeštinaČeština
Tiếng ViệtTiếng Việt
ΕλληνικάΕλληνικά
Scroll to top